Marks JR - Search Results

1

Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer.

Xing Z, Zhang Y, Liang K, Yan L, Xiang Y, Li C, Hu Q, Jin F, Putluri V, Putluri N, Coarfa C, Sreekumar A, Park PK, Nguyen TK, Wang S, Zhou J, Zhou Y, Marks JR, Hawke DH, Hung MC, Yang L, Han L, Ying H, Lin C. Xing Z, et al. Among authors: marks jr. Cancer Res. 2018 Aug 15;78(16):4524-4532. doi: 10.1158/0008-5472.CAN-17-0385. Epub 2018 Jul 2. Cancer Res. 2018. PMID: 29967256 Free PMC article.

2

Maintenance of p53 alterations throughout breast cancer progression.

Davidoff AM, Kerns BJ, Iglehart JD, Marks JR. Davidoff AM, et al. Among authors: marks jr. Cancer Res. 1991 May 15;51(10):2605-10. Cancer Res. 1991. PMID: 1850660

3

Overexpression and mutation of p53 in epithelial ovarian cancer.

Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A. Marks JR, et al. Cancer Res. 1991 Jun 1;51(11):2979-84. Cancer Res. 1991. PMID: 2032235

4

Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR. Iglehart JD, et al. Among authors: marks jr. Cancer Res. 1990 Oct 15;50(20):6701-7. Cancer Res. 1990. PMID: 2208136

5

Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.

Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW. Futreal PA, et al. Among authors: marks jr. Cancer Res. 1994 Apr 1;54(7):1791-4. Cancer Res. 1994. PMID: 7511052

6

Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.

Iglehart JD, Kerns BJ, Huper G, Marks JR. Iglehart JD, et al. Among authors: marks jr. Breast Cancer Res Treat. 1995 Jun;34(3):253-63. doi: 10.1007/BF00689717. Breast Cancer Res Treat. 1995. PMID: 7579490

7

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Among authors: marks jr. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

8

BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR. Vaughn JP, et al. Among authors: marks jr. Cell Growth Differ. 1996 Jun;7(6):711-5. Cell Growth Differ. 1996. PMID: 8780884

9

Cell cycle control of BRCA2.

Vaughn JP, Cirisano FD, Huper G, Berchuck A, Futreal PA, Marks JR, Iglehart JD. Vaughn JP, et al. Among authors: marks jr. Cancer Res. 1996 Oct 15;56(20):4590-4. Cancer Res. 1996. PMID: 8840967

10

Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells.

Elbendary AA, Cirisano FD, Evans AC Jr, Davis PL, Iglehart JD, Marks JR, Berchuck A. Elbendary AA, et al. Among authors: marks jr. Clin Cancer Res. 1996 Sep;2(9):1571-5. Clin Cancer Res. 1996. PMID: 9816335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

848 results

Search Page

Filters